ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
To access the Ondexxya (andexanet alfa) prescribing and adverse event reporting information, please click here.
For more information about Ondexxya, please visit our website: https://ondexxya.co.
Learn more about the event